Financials data is unavailable for this security.
View more
Year on year Core Laboratories Inc grew revenues 4.10% from 489.74m to 509.79m while net income improved 88.53% from 19.45m to 36.68m.
| Gross margin | 20.46% |
|---|---|
| Net profit margin | 5.19% |
| Operating margin | 11.28% |
| Return on assets | 4.55% |
|---|---|
| Return on equity | 11.02% |
| Return on investment | 5.41% |
More ▼
Cash flow in USDView more
In 2023, Core Laboratories Inc did not generate a significant amount of cash. However, the company earned 24.79m from its operations for a Cash Flow Margin of 4.86%. In addition the company used 6.65m on investing activities and also paid 18.45m in financing cash flows.
| Cash flow per share | 0.8866 |
|---|---|
| Price/Cash flow per share | 23.45 |
| Book value per share | 5.34 |
|---|---|
| Tangible book value per share | 3.08 |
More ▼
Balance sheet in USDView more
| Current ratio | 2.48 |
|---|---|
| Quick ratio | 1.79 |
| Total debt/total equity | 0.5578 |
|---|---|
| Total debt/total capital | 0.353 |
More ▼
Growth rates in USD
Year on year, growth in dividends per share remained flat while earnings per share excluding extraordinary items increased 85.71%. Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked below the industry average relative to its peers.
| Div yield(5 year avg) | 2.09% |
|---|---|
| Div growth rate (5 year) | -55.13% |
| Payout ratio (TTM) | 7.15% |
| EPS growth(5 years) | -15.48 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | -37.01 |
More ▼
